Cat. No.: HY-N0297

Copy Link Print Information

Sinensetin

(Synonyms: Pedalitin permethyl ether)

10 Cited Publications

Customer Review

Based on 10 publication(s) in Google Scholar

Sinensetin is a methylated flavonoid found in fruits that has strong anti-vascular and anti-inflammatory properties.

For research use only. We do not sell to patients.

Purity: 99.62%
CAS No.: 2306-27-6
Formula: C₂₀H₂₀O₇
Molecular Weight:372.37

Storage:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year

Sinensetin Chemical Structure

CAS No.: 2306-27-6

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Publications (10)
Solvent & Solubility
- In Vitro
- In Vivo
Purity & Documentation
References
Help & FAQs
Bioz

Biological Activity

Description

Sinensetin is a methylated flavonoid found in fruits that has strong anti-vascular and anti-inflammatory properties.

All TNF Receptor Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
3T3-L1	IC₅₀	59 μM Compound: 5, sinensetin	Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation Anticorpulence activity against mouse 3T3L1 cells assessed as inhibition of lipid droplet accumulation	[PMID: 19054677]
A2780 ADR	IC₅₀	34 μM Compound: 19	Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay Inhibition of P-gp expressed in A2780adr cells by calcein AM accumulation assay	[PMID: 21354800]
HL-60	IC₅₀	>100 μM Compound: V	Antiproliferative activity against HL60 after 24 hrs Antiproliferative activity against HL60 after 24 hrs	[PMID: 17391969]
HT-29	IC₅₀	67 μM Compound: 5, sinensetin	Anticancer activity against human HT-29 cells after 72 hrs by MTT assay Anticancer activity against human HT-29 cells after 72 hrs by MTT assay	[PMID: 19054677]
MCF-10A	IC₅₀	65 μM Compound: Sinensetin	Cytotoxicity against human MCF-10A cells assessed as inhibition of cell growth by MTT assay Cytotoxicity against human MCF-10A cells assessed as inhibition of cell growth by MTT assay	[PMID: 33257172]
MCF7	IC₅₀	8.3 μM Compound: 19	Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining	[PMID: 21354800]
MDA-MB-231	EC₅₀	268.7 μM Compound: 22	Cytotoxicity against human MDA-MB-231 cells Cytotoxicity against human MDA-MB-231 cells	[PMID: 28112509]
MDA-MB-468	IC₅₀	0.2 μM Compound: Sinensetin	Antiproliferative activity against human MDA-MB-468 cells assessed as inhibition of cell growth by MTT assay Antiproliferative activity against human MDA-MB-468 cells assessed as inhibition of cell growth by MTT assay	[PMID: 33257172]
MDCK	IC₅₀	29 μM Compound: 19	Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry Inhibition of MDR1 expressed in MDCK cells using rhodamine 123 staining by flow cytometry	[PMID: 21354800]
MDCK	IC₅₀	9 μM Compound: 19	Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining	[PMID: 21354800]
Monocyte	IC₅₀	8 μM Compound: Sinensetin	Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA	[PMID: 10096854]
Monocyte	IC₅₀	1 x 10^-5 M Compound: sinensetin	Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs	[PMID: 8882428]

In Vitro

Sinensetin (40 μM, 2 d) enhances adipogenesis of 3T3-L1 preadipocytes by up-regulating the adipogenic transcription factors in the absence of IBMX^[1].
Sinensetin (12-200 μM, 24-48 h) shows significant cytotoxic effects on Jurkat and CCRF-CEM cells in a dose-dependent and time-dependent manner^[4].
Sinensetin (100 μM, 48h) induces the sub-G1 phase and apoptosis in Jurkat cells^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

3T3-L1
Concentration:

2, 10, 40 μM
Incubation Time:

24 d
Result:

Increased cellular lipid accumulation and triglyceride content in a dose-dependent manner.
Increased the expression of PPARγ1, PPARγ2, C/EBPα, and aP2.

Cell Proliferation Assay^[4]

Cell Line:

CCRF-CEM cell, Jurkat
Concentration:

6.25–100 μM
Incubation Time:

24 or 48 h
Result:

Inhibited cell viability with different concentrations of sinensetin for 24 h and 48 h.

Apoptosis Analysis^[4]

Cell Line:

Jurkat cell
Concentration:

50 μM, 100 μM
Incubation Time:

24 h and 48 h
Result:

Induced a sub-G1 population and apoptotic.

In Vivo

Sinensetin (50 mg/kg, single dose, i.p.) has anti-inflammatory effects on carrageenan (HY-125474) induced paw inflammation in the mouse^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Carrageenan-induced paw edema in male C57BL/6 mice^[5]
Dosage:

50 mg/kg, single dose
Administration:

Intraperitoneal injection (i.p.)
Result:

Sloewd the volume increased of the carrageenan-treated paw at 6 h.

Chemical Information

CAS No. 2306-27-6
Appearance Solid
Molecular Weight 372.37
Formula C₂₀H₂₀O₇
Color White to light yellow
SMILES

O=C1C=C(C2=CC=C(OC)C(OC)=C2)OC3=CC(OC)=C(OC)C(OC)=C13
Synonyms

Pedalitin permethyl ether
Structure Classification
- Flavonoids
- Flavones
Initial Source
- Plants
- other families
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Publications (10)

All Cell Proliferation/Viability AssayWBFlow CytometryCell Imaging/StainingApoptosis Analysis

Sort by:

Journal Impact Factor

Acta Pharm Sin B

Chrysin serves as a novel inhibitor of DGK α/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). [Abstract]

2021 Jan;11(1):143-155. PMID: 33532186
Food Chem

Effects of sun drying combined with baking processes on the flavor quality of Chongqing Tuocha raw tea. [Abstract]

2025 Dec 30:497:146992. PMID: 41285060
Food Chem

Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]

2025 May 31:489:144992. PMID: 40466530
Food Funct

Sinensetin attenuates IL-1β-induced cartilage damage and ameliorates osteoarthritis by regulating SERPINA3. [Abstract]

2022 Oct 3;13(19):9973-9987. PMID: 36056701
Nutrients

Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells. [Abstract]

2020 Aug 15;12(8):2462. PMID: 32824273

Sinensetin purchased from MedChemExpress. Usage Cited in: Nutrients. 2020 Aug 15;12(8):2462. [Abstract]

HepG2 and Thle2 cells were treated with indicated concentrations of Sinensetin (SIN) (0, 25, 50, 75, and 100 μM) for 24 h or 48 h, and cell viability was determined by the MTT assay.

Sinensetin purchased from MedChemExpress. Usage Cited in: Nutrients. 2020 Aug 15;12(8):2462. [Abstract]

HepG2 cells were treated with Sinensetin (SIN) (0, 50, 100 μM) for 48 h. Immunoblotting analysis of apoptosis markers, cleaved-PARP, cleaved-caspase-3, and Bcl-xL, was performed.

Sinensetin purchased from MedChemExpress. Usage Cited in: Nutrients. 2020 Aug 15;12(8):2462. [Abstract]

HepG2 cells were treated with Sinensetin (SIN) (0, 50, 100 μM) for 48 h, then fixed and stained with propidium iodide (PI). Cell cycle was analyzed with flow cytometry.

Sinensetin purchased from MedChemExpress. Usage Cited in: Nutrients. 2020 Aug 15;12(8):2462. [Abstract]

The images above shows HepG2 cells treated with Sinensetin (SIN) (0, 50, 100 μM) for 48 h. The cell morphology was examined by phase-contrast microscopy.

Sinensetin purchased from MedChemExpress. Usage Cited in: Nutrients. 2020 Aug 15;12(8):2462. [Abstract]

Apoptosis was identified by annexin V-propidium iodide (PI) staining and analyzed by flow cytometry treated with Sinensetin (SIN) (0, 50, 100 μM).
Front Pharmacol

Sinensetin Reduces Osteoarthritis Pathology in the Tert-Butyl Hydroperoxide-Treated Chondrocytes and the Destabilization of the Medial Meniscus Model Mice via the AMPK/mTOR Signaling Pathway. [Abstract]

2021 Jul 16:12:713491. PMID: 34335275
J Biochem Mol Toxicol

Sinensetin inhibits the movement ability and tumor immune microenvironment of non-small cell lung cancer through the inactivation of AKT/β-catenin axis. [Abstract]

2024 Nov;38(11):e70024. PMID: 39434434
J Appl Toxicol

Sinensetin attenuates oxygen-glucose deprivation/reperfusion-induced neurotoxicity by MAPK pathway in human cerebral microvascular endothelial cells. [Abstract]

2022 Apr;42(4):683-693. PMID: 34664717
Cell Biochem Biophys

Sinensetin Inhibits Angiogenesis in Lung Adenocarcinoma via the miR-374c-5p/VEGF-A/VEGFR-2/AKT Axis. [Abstract]

2024 Sep;82(3):2413-2425. PMID: 39030333
J Oleo Sci

Characterization of Essential Oil Composition, Polymethoxyflavones, Total Carotenoids, and Sensory Properties of Japanese and Taiwanese Hirami Lemon (Citrus depressa Hayata). [Abstract]

2026;75(4):465-476. PMID: 41922207

Solvent & Solubility

In Vitro:

DMSO : 18.18 mg/mL (48.82 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.6855 mL

13.4275 mL

26.8550 mL

5 mM

0.5371 mL

2.6855 mL

5.3710 mL

10 mM

0.2686 mL

1.3428 mL

2.6855 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 1.25 mg/mL (3.36 mM); Clear solution

This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 1.25 mg/mL (3.36 mM); Clear solution

This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (280 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Kang SI et al. Sinensetin enhances adipogenesis and lipolysis by increasing cyclic adenosine monophosphate levels in 3T3-L1 adipocytes. Biol Pharm Bull. 2015;38(4):552-8. [Content Brief]

[2]. Shin HS et al. Sinensetin attenuates LPS-induced inflammation by regulating the protein level of IκB-α. Biosci Biotechnol Biochem. 2012;76(4):847-9. [Content Brief]

[3]. Lam IK et al. In vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: identifying sinensetin as a novel antiangiogenesis agent. Mol Nutr Food Res. 2012 Jun;56(6):945-56. [Content Brief]

[4]. Kok-Tong Tan, et al. Sinensetin induces apoptosis and autophagy in the treatment of human T-cell lymphoma. Anticancer Drugs. 2019, 30, 5. [Content Brief]

[5]. Mirka Laavola, et al. Flavonoids eupatorin and sinensetin present in Orthosiphon stamineus leaves inhibit inflammatory gene expression and STAT1 activation. Planta Med. 2012, 78, 8. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.6855 mL	13.4275 mL	26.8550 mL	67.1375 mL
	5 mM	0.5371 mL	2.6855 mL	5.3710 mL	13.4275 mL
	10 mM	0.2686 mL	1.3428 mL	2.6855 mL	6.7138 mL
	15 mM	0.1790 mL	0.8952 mL	1.7903 mL	4.4758 mL
	20 mM	0.1343 mL	0.6714 mL	1.3428 mL	3.3569 mL
	25 mM	0.1074 mL	0.5371 mL	1.0742 mL	2.6855 mL
	30 mM	0.0895 mL	0.4476 mL	0.8952 mL	2.2379 mL
	40 mM	0.0671 mL	0.3357 mL	0.6714 mL	1.6784 mL

Keywords

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Sinensetin

Apoptosis Compound Library

Immunology/Inflammation Compound Library

Natural Product Library

Differentiation Inducing Compound Library

Medicine Food Homology Compound Library

Traditional Chinese Medicine Active Compound Library

FDA Approved & Pharmacopeial Drug Library

Flavonoids Library

Angiogenesis-Related Compound Library

Food-Sourced Compound Library

Anti-Cancer Natural Product Library

Antidepressant Compound Library

Anti-inflammatory Traditional Chinese Medicine Active Compound Library

Plant-Sourced Natural Product Library

Human Metabolite Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Mitochondrial Protection Compound Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

Autoimmune Disease Compound Library

Cytokine Inhibitors Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Heat-Clearing and Detoxification Traditional Chinese Medicine Compound Library

RO5 Drug-like Natural Product Library

Flavor Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Anti-Rheumatic Arthritis Compound Library

Mass Spectrometry Human Metabolite Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mongolian Medicine Compound Library

Mass Spectrometry Natural Product Library

Publications Citing Use of MedChemExpress (MCE) Sinensetin

All TNF Receptor Isoforms

Biological Activity

Chemical Information

Publications (10)

Solvent & Solubility

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

Sinensetin Related Classifications

Cat. No.: HY-N0297